Tilarginine citrate

TargetMol
Product Code: TAR-T26277L
Supplier: TargetMol
CodeSizePrice
TAR-T26277L-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26277L-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26277L-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Tilarginine citrate is a competitive nitric oxide synthetase inhibitor.
CAS:
209913-88-2
Formula:
C13H24N4O9
Molecular Weight:
380.35
Purity:
0.98
SMILES:
N[C@@H](CCCNC(NC)=N)C(O)=O.O=C(CC(C(O)=O)(O)CC(O)=O)O

References

1. Ricciardolo FL, Rado V, Fabbri LM, Sterk PJ, Di Maria GU, Geppetti P. Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med. 1999 Feb;159(2):557-62. PubMed PMID: 9927373. 2. Kimura M, Higashi Y, Hara K, Noma K, Sasaki S, Nakagawa K, Goto C, Oshima T, Yoshizumi M, Chayama K. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers. Hypertension. 2003 May;41(5):1106-10. Epub 2003 Apr 14. PubMed PMID: 12695418. 3. Kaluski E, Uriel N, Milo-Cotter O, Klapholz M. Nitric oxide synthase inhibitors in cardiogenic shock: present and future. Future Cardiol. 2008 Mar;4(2):183-9. doi: 10.2217/14796678.4.2.183. PubMed PMID: 19804295. 4. Clancy RM, Gomez PF, Abramson SB. Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes. Osteoarthritis Cartilage. 2004 Jul;12(7):552-8. PubMed PMID: 15219570.